Michael Moore

Michael Moore discloses dealings in Viemed Healthcare, Inc. to SEC (Form 4). Over a trading history stretching from 21 December 2017 to 20 August 2026, the count stands at 42 filings.

The open-market side counts 2 purchases for €62k alongside 18 sales for €3.7M. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 15 option exercises. Since January 2026: no purchases and 3 sales on the market.

The newest entry dates from 20 August 2026: a transaction, in Viemed Healthcare, Inc. The latest purchase dates back some time: it was published 2,894 days ago, on 20 November 2018. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.